Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Mayo Clinic

Overview

Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.

To determine if serum biomarkers of inflammation correlate with onset and severity of acute GVHD, particularly GVHD of the gut.

Study Type

OBSERVATIONAL

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years old or older patients * Undergoing allogeneic stem cell transplant Exclusion Criteria: None

Mayo Clinic

Rochester, Minnesota, United States

Diagnosis of severe acute GVHD

Time frame: 2 months

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.